October 8, 2025 — Leads & Copy — Claritev Corporation (NYSE: CTEV) and iO Health-FZE have announced a strategic agreement to deliver Optima AI across the Middle East and North Africa (MENA). Claritev secures exclusive rights to license, integrate, and resell iO Health’s Optima AI platform in the MENA region. Optima AI streamlines financial and administrative processes for healthcare providers, reducing claim denials and optimizing workflows.
The integration of Optima AI into Claritev’s suite will enable hospitals, clinics, and payors to improve claims management efficiency through advanced analytics. Travis Dalton, President & CEO of Claritev, notes this partnership as a pivotal step in Claritev’s global expansion, bringing AI technology to healthcare providers in MENA to improve financial health and reduce administrative burden.
Dr. Haidar Al Yousuf, CEO of iO Health, emphasizes that this collaboration redefines how healthcare providers in MENA approach financial sustainability. The goal is to empower stakeholders to recover revenue faster, reduce inefficiencies, and create a patient-centric healthcare ecosystem.
Under the agreement, Claritev and iO Health will collaborate on implementation and support to ensure healthcare organizations can maximize the partnership’s value. Claritev, formerly known as MultiPlan, focuses on improving affordability and transparency in healthcare, serving over 700 healthcare payors and 60 million consumers.
iO Health, founded in 2021, has established itself as a healthcare AI company in the MENA region, dedicated to designing intelligent care journeys. Its Optima RCM platform aims to streamline reimbursements and improve healthcare outcomes.
Contact:
Travis Dalton, President & CEO, Claritev
Source: Claritev
